Correction: Severe gastrointestinal involvements in patients with adult dermatomyositis with anti-NXP2 antibody

Correction: Severe gastrointestinal involvements in patients with adult dermatomyositis with anti-NXP2 antibody

Dades bibliogràfiques
Format:	Article
Idioma:	English
Publicat:	BMJ Publishing Group 2024-02-01
Col·lecció:	RMD Open
Accés en línia:	https://rmdopen.bmj.com/content/10/1/e003901corr1.full

Ítems similars

Severe gastrointestinal involvements in patients with adult dermatomyositis with anti-NXP2 antibody
per: Zhiwei Chen, et al.
Publicat: (2024-02-01)

Interstitial lung disease in an adult patient with dermatomyositis and anti-NXP2 autoantibody
per: Morgane Gossez, et al.
Publicat: (2015-06-01)

Early improvement of nailfold videocapillaroscopy abnormalities in dermatomyositis patients with anti‐NXP‐2 antibody
per: Naoki Mugii, et al.
Publicat: (2023-12-01)

Complete, refractory dysphagia in a dermatomyositis patient with positive anti-NXP-2 antibodies
per: Claudia Cobilinschi, et al.
Publicat: (2021-12-01)

Anti-NXP2 antibody positive dermatomyositis presenting as unilateral heliotrope rash
per: Zeinab F. Saleh, MD, et al.
Publicat: (2024-08-01)

Gastrointestinal perforation in anti-NXP2 antibody-associated juvenile dermatomyositis: case reports and a review of the literature
per: Yingjie Xu, et al.
Publicat: (2021-01-01)

A Case of Dermatomyositis Coexisting with Both Anti-Mi-2 and Anti-NXP-2 Antibodies
per: Mitsuru Ito, et al.
Publicat: (2020-05-01)

Anti‐MJ/NXP‐2 antibody‐positive adult‐onset dermatomyositis with lichen myxedematosus and endometrial carcinoma
per: Kimiko Nakajima, et al.
Publicat: (2021-12-01)

Atypical presentation of anti-NXP-2 positive juvenile dermatomyositis
per: Andreia Coimbra-Sousa, et al.
Publicat: (2023-10-01)

A case of anti‐NXP‐2‐positive dermatomyositis with generalized subcutaneous edema
per: Yukinobu Nakagawa, et al.
Publicat: (2020-10-01)

NXP-2 Positive Dermatomyositis: A Unique Clinical Presentation
per: Zeeshan Butt, et al.
Publicat: (2017-01-01)

Possible correlation between serum interleukin-8 levels and the activity of myositis in anti-NXP2 antibody-positive dermatomyositis
per: Risa Konishi, et al.
Publicat: (2024-04-01)

Corrigendum to “NXP-2 Positive Dermatomyositis: A Unique Clinical Presentation”
per: Zeeshan Butt, et al.
Publicat: (2018-01-01)

Clinical Images: Degos‐like lesions in association with NXP‐2 dermatomyositis
per: Eaman Alhassan, et al.
Publicat: (2023-09-01)

Acute onset dermatomyositis with NXP‐2 antibodies after Sars‐CoV‐2 vaccination in a 20‐year‐old female
per: Emma Porter, et al.
Publicat: (2023-06-01)

Gastrointestinal Involvement in Dermatomyositis
per: Ana Matas-Garcia, et al.
Publicat: (2022-05-01)

Rapidly progressive interstitial pneumonia associated with anti-NXP2 antibody secondary to malignancy
per: Nataphon Wuthithepbuncha, et al.
Publicat: (2022-01-01)

Clinical characteristics and poor predictors of anti-NXP2 antibody-associated Chinese JDM children
per: Xinning Wang, et al.
Publicat: (2021-01-01)

Gastrointestinal Ulceration as a Manifestation of Severe Dermatomyositis -
per: Daniel O’Shea
Publicat: (2023-05-01)

Anti-MDA5 antibody-positive dermatomyositis with severe cutaneous ulcers
per: Büşra Demirbağ Gül, et al.
Publicat: (2022-12-01)

Anti-MDA5 Antibodies in a Large Mediterranean Population of Adults with Dermatomyositis
per: Moises Labrador-Horrillo, et al.
Publicat: (2014-01-01)

Myocardial involvement is not rare in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis/clinically amyopathic dermatomyositis: a retrospective study
per: Shuang Zhou, et al.
Publicat: (2022-08-01)

Bullous dermatomyositis with anti-NPX2 antibodies, associated with breast cancer
per: Francisca Reculé, et al.
Publicat: (2024-04-01)

Dermatomyositis with positive anti‐TIF1 gamma antibodies in an adult female: A case report
per: Krishna Adhikari, et al.
Publicat: (2023-11-01)

Type I interferon score is associated with the severity and poor prognosis in anti-MDA5 antibody-positive dermatomyositis patients
per: Jinjing Qian, et al.
Publicat: (2023-03-01)

An implementation of ergonomics in working environment at NXP Semiconductors Malaysia / Norbaizura Shamaruddin
per: Shamaruddin, Norbaizura
Publicat: (2011)

Clinical characteristics of anti-SAE antibodies in Chinese patients with dermatomyositis in comparison with different patient cohorts
per: Yongpeng Ge, et al.
Publicat: (2017-03-01)

Dermatomyositis involving muscles and fasciae
per: Hongwei Tan, et al.
Publicat: (2024-10-01)

Respiratory involvement in juvenile dermatomyositis
per: Fabi M, et al.
Publicat: (2008-09-01)

Diagnosis of neuropsychiatry disorder in patients with anti-MDA5 antibody dermatomyositis: A case report
per: Yida Xing, et al.
Publicat: (2023-12-01)

Cutaneous Features of Anti-MDA-5 Antibody-Positive Amyopathic Dermatomyositis in a Sudanese Patient
per: Nouf Alqahtani, et al.
Publicat: (2021-09-01)

Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies
per: Anaïs Nombel, et al.
Publicat: (2021-10-01)

Infection Risk in Patients with Dermatomyositis Associated with Anti-MDA5 Antibodies: A Historical Cohort Study
per: Anne-Claire Billet, et al.
Publicat: (2022-12-01)

Amyopathic anti‐TIF1‐γ antibody‐positive dermatomyositis in a young man
per: Nicolas Kluger
Publicat: (2024-07-01)

A Rare Case of Anti-TIF-1γ Antibody Positive Dermatomyositis in Adulthood
per: Upasana Agrawal MD, et al.
Publicat: (2024-06-01)

Gastrointestinal Involvement in Primary Antibody Deficiencies
per: Tomas Milota, et al.
Publicat: (2023-01-01)

Presence and Implications of Anti‐Angiotensin Converting Enzyme‐2 Immunoglobulin M Antibodies in Anti‐Melanoma‐Differentiation‐Associated 5 Dermatomyositis
per: Christopher A. Mecoli, et al.
Publicat: (2022-05-01)

The performance of NXP Semiconductors Sdn Bhd: analysis based on profitability and creditability / Nur Asmiza Amirnuddin
per: Amirnuddin, Nur Asmiza
Publicat: (2010)

NXP032 ameliorates cognitive impairment by alleviating the neurovascular aging process in aged mouse brain
per: Jae-Min Lee, et al.
Publicat: (2023-05-01)

Correction: Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review
per: Kentaro Nishi, et al.
Publicat: (2022-09-01)